NYSE:MET - Metlife Stock Price, Price Target & More

Metlife trades on the New York Stock Exchange (NYSE) under the ticker symbol "MET."

Metlife declared a quarterly dividend on Friday, July 6th. Stockholders of record on Monday, August 6th will be paid a dividend of $0.42 per share on Thursday, September 13th. This represents a $1.68 dividend on an annualized basis and a dividend yield of 3.80%. The ex-dividend date of this dividend is Friday, August 3rd. View Metlife's Dividend History.

Metlife announced that its board has authorized a share repurchase program on Tuesday, May 22nd 2018, which permits the company to repurchase $1,500,000,000.00 in shares, according to EventVestor. This repurchase authorization permits the company to purchase up to 3.1% of its stock through open market purchases. Stock repurchase programs are typically a sign that the company's board believes its stock is undervalued.

Metlife Inc (NYSE:MET) posted its quarterly earnings results on Wednesday, May, 2nd. The financial services provider reported $1.36 earnings per share for the quarter, topping the Zacks' consensus estimate of $1.17 by $0.19. The financial services provider earned $15.15 billion during the quarter, compared to analysts' expectations of $15.52 billion. Metlife had a net margin of 6.48% and a return on equity of 8.70%. The company's revenue for the quarter was up .6% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.20 earnings per share. View Metlife's Earnings History.

17 brokerages have issued 12-month price targets for Metlife's shares. Their predictions range from $47.00 to $78.00. On average, they expect Metlife's share price to reach $56.60 in the next year. This suggests a possible upside of 28.1% from the stock's current price. View Analyst Ratings for Metlife.

17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Metlife in the last year. There are currently 9 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Hold."

Metlife saw a decline in short interest in June. As of June 29th, there was short interest totalling 12,020,672 shares, a decline of 28.9% from the June 15th total of 16,900,543 shares. Based on an average daily volume of 7,086,353 shares, the short-interest ratio is currently 1.7 days. Currently, 1.4% of the shares of the company are sold short. View Metlife's Current Options Chain.

Some companies that are related to Metlife include China Life Insurance (LFC), Prudential Public (PUK), AXA (AXAHY), Prudential Financial (PRU), Manulife Financial (MFC), SWISS RE Ltd/S (SSREY), AVIVA PLC/ADR (AVVIY), Sun Life Financial (SLF), HANNOVER RUECK/S (HVRRY), Legal & General Group (LGEN), AMP (AMP), Lincoln National (LNC), OLD Mut PLC/ADR (ODMTY), AEGON (AEG) and Torchmark (TMK).

Media stories about MET stock have been trending somewhat positive on Wednesday, according to Accern. The research group scores the sentiment of press coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Metlife earned a coverage optimism score of 0.20 on Accern's scale. They also gave news headlines about the financial services provider an impact score of 46.01 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the next several days.

Metlife's stock is owned by a number of of retail and institutional investors. Top institutional investors include BOARD OF DIRECTORS OF METLIFE INC (15.00%), Bank of Montreal Can (0.19%), NN Investment Partners Holdings N.V. (0.17%), Retirement Systems of Alabama (0.06%), Deprince Race & Zollo Inc. (0.05%) and Lodestar Investment Counsel LLC IL (0.04%). Company insiders that own Metlife stock include Christopher G Townsend, Frans Hijkoop, Gerald L Hassell, James M Kilts, Maria R Morris and Peter M Carlson. View Institutional Ownership Trends for Metlife.

MET stock was sold by a variety of institutional investors in the last quarter, including Bank of Montreal Can, Calamos Advisors LLC, Welch & Forbes LLC, Gofen & Glossberg LLC IL, Deprince Race & Zollo Inc., Gateway Investment Advisers LLC, Cullinan Associates Inc. and Franklin Street Advisors Inc. NC. View Insider Buying and Selling for Metlife.

MET stock was purchased by a variety of institutional investors in the last quarter, including Howard Capital Management Inc., Capital One National Association, Retirement Systems of Alabama, Farmers Trust Co., DAVENPORT & Co LLC, NN Investment Partners Holdings N.V., Addenda Capital Inc. and State of Alaska Department of Revenue. Company insiders that have bought Metlife stock in the last two years include Gerald L Hassell and James M Kilts. View Insider Buying and Selling for Metlife.

Shares of MET can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of MET stock can currently be purchased for approximately $44.19.

Metlife has a market capitalization of $45.17 billion and generates $62.09 billion in revenue each year. The financial services provider earns $4.01 billion in net income (profit) each year or $4.50 on an earnings per share basis. Metlife employs 49,000 workers across the globe.

Metlife's mailing address is 200 Park Avenue, New York NY, 10166. The financial services provider can be reached via phone at 212-578-9500.